Sandu Pharmaceuticals fundamental analysis

SANDUPHQ

34.8

0.22 (-0.63%)
Last updated on 13 Feb, 2026 | 15:10 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Sandu Pharmaceuticals Fundamentals

P/E Ratio

21.66

P/B Ratio

1.01

Div. Yield

2.3

Sector P/E

65.34

Sector P/B

2.79

Sec. Div. Yield

0.57

Sandu Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 21.66, compared to the sector average of 65.34. Its P/B Ratio stands at 1.01, while the sector’s is 2.79. In terms of returns, the stock offers a Dividend Yield of 2.3%, which is than the sector’s 0.57%.

Sandu Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Sandu Pharmaceuticals reflects: Price – Attractive, Growth – Poor, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.